{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:46:38Z","timestamp":1791002798309,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T00:00:00Z","timestamp":1551916800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Genethon"},{"name":"French Muscular Dystrophy Association"},{"name":"European Union\u2019s research and innovation program","award":["667751"],"award-info":[{"award-number":["667751"]}]},{"name":"European Union\u2019s research and innovation program","award":["658712"],"award-info":[{"award-number":["658712"]}]},{"name":"ASTRE laboratories of the Essonne"},{"name":"Italian Telethon","award":["GGP15051"],"award-info":[{"award-number":["GGP15051"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ymthe.2017.12.019","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T20:03:53Z","timestamp":1514405033000},"page":"890-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression"],"prefix":"10.1016","volume":"26","author":[{"given":"Patrice","family":"Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Pagliarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"Colella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Costa Verdera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Jauze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Gjorgjieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Puzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solenne","family":"Marmier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Collaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Simon Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Lucchiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"van Wittenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Vignaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Gjata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Laforet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Malfatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Mithieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Rajas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo Pietro","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ronzitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mingozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2017.12.019_bib1","series-title":"GeneReviews","article-title":"Glycogen Storage Disease Type III","author":"Dagli","year":"2010"},{"key":"10.1016\/j.ymthe.2017.12.019_bib2","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10545-016-9932-2","article-title":"Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome","volume":"39","author":"Sentner","year":"2016","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2017.12.019_bib3","series-title":"Myology","first-page":"1535","article-title":"Metabolic disorders affecting muscle","author":"Di Mauro","year":"2004"},{"key":"10.1016\/j.ymthe.2017.12.019_bib4","first-page":"72","article-title":"Clinical, biochemical and genetic features of glycogen debranching enzyme deficiency","volume":"26","author":"Lucchiari","year":"2007","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymthe.2017.12.019_bib5","first-page":"631","article-title":"Cornstarch therapy in a patient with type III glycogen storage disease","volume":"6","author":"Borowitz","year":"1987","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymthe.2017.12.019_bib6","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1203\/PDR.0b013e318232154f","article-title":"Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet","volume":"70","author":"Valayannopoulos","year":"2011","journal-title":"Pediatr. Res."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2017.12.019_bib7","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1007\/s10545-009-1088-x","article-title":"Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet","volume":"32","author":"Dagli","year":"2009","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2017.12.019_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in\u00a0vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2017.12.019_bib9","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.12.019_bib10","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2017.12.019_bib11","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.88.16_supplement.CT.003","article-title":"AVXS-101 Phase 1 Gene Therapy Clinical Trial in SMA Type 1: Event Free Survival and Achievement of Developmental Milestones","volume":"88","author":"Mendell","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ymthe.2017.12.019_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2017.02.004","article-title":"Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs","volume":"25","author":"Mack","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib13","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/hmg\/ddv310","article-title":"Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus","volume":"24","author":"Yue","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.12.019_bib14","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1038\/mtm.2015.9","article-title":"A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2\u2009kb Dysferlin coding sequence","volume":"2","author":"Pryadkina","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2017.12.019_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/emmm.201302948","article-title":"Effective delivery of large genes to the retina by dual AAV vectors","volume":"6","author":"Trapani","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2017.12.019_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/hum.2010.122","article-title":"Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences","volume":"22","author":"Ghosh","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymthe.2017.12.019_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ymgme.2012.12.002","article-title":"Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for glycogen storage disease type III","volume":"108","author":"Sun","year":"2013","journal-title":"Mol.\u00a0Genet. Metab."},{"key":"10.1016\/j.ymthe.2017.12.019_bib19","doi-asserted-by":"crossref","first-page":"eaam6375","DOI":"10.1126\/scitranslmed.aam6375","article-title":"Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid \u03b1-glucosidase","volume":"9","author":"Puzzo","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2017.12.019_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.mt.6300322","article-title":"A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner","volume":"16","author":"Ghosh","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib21","doi-asserted-by":"crossref","first-page":"16049","DOI":"10.1038\/mtm.2016.49","article-title":"A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome","volume":"3","author":"Ronzitti","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2017.12.019_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2017.12.019_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/JVI.72.1.180-190.1998","article-title":"Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB","volume":"72","author":"L\u00f6ser","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2017.12.019_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1006\/mthe.2000.0075","article-title":"Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in\u00a0vivo but not in\u00a0vitro","volume":"1","author":"Miao","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib25","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2017.12.019_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1152\/physrev.1975.55.4.609","article-title":"Glycogen metabolism and glycogen-storage diseases","volume":"55","author":"Huijing","year":"1975","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2017.12.019_bib27","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00109-014-1127-4","article-title":"Correction of glycogen storage disease type III with rapamycin in a canine model","volume":"92","author":"Yi","year":"2014","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.ymthe.2017.12.019_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13023-014-0196-3","article-title":"Glycogen storage disease type III: modified Atkins diet improves myopathy","volume":"9","author":"Mayorandan","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2017.12.019_bib29","first-page":"91","article-title":"Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III","volume":"17","author":"Brambilla","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymthe.2017.12.019_bib30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10545-014-9756-x","article-title":"Dietary management in glycogen storage disease type III: what is the evidence?","volume":"38","author":"Derks","year":"2015","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2017.12.019_bib31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/hum.2016.099","article-title":"Systemic Correction of Murine Glycogen Storage Disease Type IV by an AAV-Mediated Gene Therapy","volume":"28","author":"Yi","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib32","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1038\/ncomms11229","article-title":"Crystal structure of glycogen debranching enzyme and insights into its catalysis and disease-causing mutations","volume":"7","author":"Zhai","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2017.12.019_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/hum.2013.213","article-title":"Similar therapeutic efficacy between a single administration of gene therapy and multiple administrations of recombinant enzyme in a mouse model of lysosomal storage disease","volume":"25","author":"Ferla","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/mt.2011.220","article-title":"Liver production of sulfamidase reverses peripheral and ameliorates CNS pathology in mucopolysaccharidosis IIIA mice","volume":"20","author":"Ruzo","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib35","doi-asserted-by":"crossref","first-page":"6811","DOI":"10.1093\/hmg\/ddv386","article-title":"Improved dual AAV vectors with reduced expression of truncated proteins are safe and effective in the retina of a mouse model of Stargardt disease","volume":"24","author":"Trapani","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.12.019_bib36","first-page":"65","article-title":"Cardiac Pathology in Glycogen Storage Disease Type III","volume":"6","author":"Austin","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymthe.2017.12.019_bib37","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nature13864","article-title":"Promoterless gene targeting without nucleases ameliorates haemophilia B in mice","volume":"517","author":"Barzel","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.12.019_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","article-title":"In\u00a0vivo genome editing restores haemostasis in a mouse model of haemophilia","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2017.12.019_bib39","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2006.09.022","article-title":"Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?","volume":"46","author":"Demo","year":"2007","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2017.12.019_bib40","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2007-03-080093","article-title":"Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver","volume":"110","author":"Mingozzi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2017.12.019_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1006\/mthe.2001.0441","article-title":"Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9","volume":"4","author":"Fields","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib42","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2014.114","article-title":"Liver-specific transcriptional modules identified by genome-wide in\u00a0silico analysis enable efficient gene therapy in mice and non-human primates","volume":"22","author":"Chuah","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib43","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/1043034041648453","article-title":"Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector","volume":"15","author":"Liu","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib44","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coviro.2016.07.006","article-title":"Systemic delivery of adeno-associated viral vectors","volume":"21","author":"Duan","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2017.12.019_bib45","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/mt.2014.151","article-title":"Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients","volume":"22","author":"Le Guiner","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acn3.172","article-title":"AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models","volume":"2","author":"Sondergaard","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ymthe.2017.12.019_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1089\/hum.2013.164","article-title":"Triple trans-splicing adeno-associated virus vectors capable of transferring the coding sequence for full-length dystrophin protein into dystrophic mice","volume":"25","author":"Koo","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib48","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/hmg\/ddq065","article-title":"Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer","volume":"19","author":"Lostal","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2017.12.019_bib49","unstructured":"Mendell, J.R. (2016). rAAVrh74.MHCK7.DYSF.DV for treatment of dysferlinopathies. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02710500."},{"key":"10.1016\/j.ymthe.2017.12.019_bib50","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1432-1033.1967.tb00133.x","article-title":"The determination of amylo-1,6-glucosidase","volume":"2","author":"Hers","year":"1967","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymthe.2017.12.019_bib51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/hum.2011.063","article-title":"Immunodominant liver-specific expression suppresses transgene-directed immune responses in murine pompe disease","volume":"23","author":"Zhang","year":"2012","journal-title":"Hum.\u00a0Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","article-title":"Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib53","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/sj.gt.3300680","article-title":"Adeno-associated virus vectors can be efficiently produced without helper virus","volume":"5","author":"Matsushita","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2017.12.019_bib54","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/gt.2009.157","article-title":"High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency","volume":"17","author":"Ayuso","year":"2010","journal-title":"Gene Ther."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617306160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001617306160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:50:50Z","timestamp":1761501050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001617306160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1525001617306160"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.12.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2017.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}